The US contact lenses market is expected to grow at a CAGR of $% from 2022 to 2028 with an increasing number of eye inaccuracies among the younger population.
The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.
Screen-weary patients have questions, and eye docs with the answers are rewarded with loyalty and referrals.